최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기환경독성학회지 = Journal of environmental toxicology, v.18 no.1, 2003년, pp.27 - 32
Kang, Byung-Yong (Research Institute for life Science, Sahmyook University) , Kim, Seon-Jeong (Dept. of Life Science, Sahmyook University) , Jang, Dai-Ho (Dept. of Life Science, Sahmyook University) , Kim, Hyun-Hee (Dept. of Life Science, Sahmyook University) , Lee, Kang-Oh (Dept. of Life Science, Sahmyook University)
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Anderson S, Bankier AT, Barrel BG, DeBruijin M, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith A, Staden R and Young IG. Sequence and organization of the human mitochondrial genome, Nature 1981; 290: 457-465
Bae JS, Kang BY, Lee KO, Yoon TJ, Kim JH and Kim KT. Haplotype distribution of the ${\beta}_2-adrenergic$ receptor gene in Korean essential ypertensives. J. Toxicol. Pub. Health. 2002; 18: 233-240
Biron P, Mongeau JG and Bertrand D. Familial aggregation of blood pressure in 558 adopted children, Can. Med. Assoc. J. 1976; 115: 773-774
Bostein D, White RL, Skolnick M and Davis RW. Construction of a genetic linkage map in man using restriction fragment length polymorphisms, Am. J. Hum. Genet. 1980; 32: 314-331
Cann RL, Stoneking M and Wilson AC. Mitochondrial DNA and human evolution. Nature 1987; 325: 31-36
Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G and Bianchi G, Association of the ${\alpha}-adducin$ locus with essential hypertension, Hypertension 1995; 25: 320-326
Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L and Bianchi G. Polymorphisms of $\alpha$ -adducin and salt sensitivity in patients with essential hypertension, Lancet 1997; 349: 1353-1357
Dahl H-HM and Thorburn DR. Mitochondrial diseases: beyond the magic circle, Am. J. Med. Genet. 2001; 106: 1-3
Dimauro S and Schon EA. Mitochondrial DNA mutations in human disease, Am. J. Med. Genet. 2001; 106: 18-26
Fridewald WT, Levy RI and Friedrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge, Clin. Chern. 1972; 18: 499-502
Frossard PM, Obineche EN, Elshahat YI, Lestringant GG, John A and Parvez SH. Association study of mutation $G^{-75}$ to A in the promoter of the human apolipoprotein AI gene and essential hypertension, Biogenic Amines 1998; 14: 91-100
Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X and Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro, J. Clin. Invest. 1997; 99: 1786-1797
Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton R, Williams C, Charm A, Hunt S, Hopkins P, Williams R, Lalouel JM and Corvol P. Molecular basis of human hypertension: the role of angiotensinogen, Cell 1992; 71: 169-180
Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Sekine Y, Teruya K, Takeda N, Satoh M, Sumiya Y, Uchida Y and Takashima Y. Association of the longevity-associated mitochondrial DNA 5178 A/C polymorphism with serum protein fraction levels in healthy Japanese women, Exp. Gerontol. 2002; 37: 931-936
Kokaze A, Ishikawa M, Matsunaga N, Yoshida M, Sekine Y, Teruya K, Takeda N, Sumiya Y, Uchida Y and Takashima Y. Association of the mitochondrial DNA 5178 A/C polymorphism with serum lipid levels in the Japanese population, Hum. Genet. 2001; 109: 521-525
Kurtz TW and Spence MA. Genetics of essential hypertension, Am. J. Med. 1993; 94: 77-84
Lifton RP and Jeunemaitre X. Finding genes that cause human hypertension, J. Hypertens. 1993; 11: 231-236
Lifton RP. Molecular genetics of human blood pressure variation, Science 1996; 272: 676-680
Matsunaga H, Tanaka Y, Tanaka M, Gong J-S, Zhang J, Nomiyama T, Ogawa O, Ogihara T, Yamada Y, Yagi K and Kawamori R. Antiatherogenic mitochondrial genotype in patients with type 2 diabetes, Diabetes Care 2001; 24: 500-503
Niemi A-K, Hervonen A, Hurme M, Karhunen PJ, Jylha M and Majamaa K. Mitochondrial DNA polymorphisms associated with longevity in a Finnish population, Hum. Genet. 2003; 112: 29-33
Orth M and Schapira AHV. Mitochondria and degenerative disorders, Am. J. Med. Genet. 2001; 106: 27-36
Raha S and Robinson BH. Mitochondria, oxygen free radicals and apoptosis, Am. J. Med. Genet. 2001; 106: 62-70
Shin JH, Kang, BY, Lee KH, Lee CC and Kim KT. Association between genetic variation in the human factor VII gene and essential hypertension in Korean population. Environ, Mutagens Carcinogens 2001; 21: 106-112
Shoji M, Tsutaya S, Kasai T and Yasujima M. Implication of single nucleotide polymorphisms in association study: mitochondrial variations as another genetic markers for hypertension, Rinsho. Byori. 2002; 50: 497-501
Soma M, Nakayama T and Katuo K. Nitric oxide synthase gene polymorphism and its influence on cardiovascular disease, Curro Opin. Nephrol. Hypertens. 1999; 8: 83-87
Tanaka M, Gong J-S, Zhang J, Yoneda M and Yagi K. Mitochondrial genotype associated with longevity, Lancet 1998; 351: 185-186
Thorburn DR and Dahl H-HM. Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options, Am. J. Med. Genet. 2001; 106: 102-114
Ward R, Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM (eds). Hypertension, Pathophysiology, Diagnosis and Management. Raven Press: New York, 1990; 81-100
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.